An analysis of the clinical value of CHI3L1 as a biomarker of multiple myeloma progression

This publication has 22 references indexed in Scilit:

• Update on kidney injury caused by multiple myeloma
  Annals of Hematology, 2024
• Molecular Pathogenesis of Multiple Myeloma
  Hematology/Oncology Clinics of North America, 2024
• Immune-Pathogenesis of Myeloma
  Hematology/Oncology Clinics of North America, 2024
• Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
  Experimental & Molecular Medicine, 2024
• Incidence of multiple myeloma in Kailuan cohort: A prospective community-based study in China
  Cancer Epidemiology, 2022
• Possible mechanism of CHI3L1 promoting tonsil lymphocytes proliferation in children with obstructive sleep apnea syndrome
  Pediatric Research, 2021
• A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL‐13Rα2‐mediated JNK‐AP‐1 signals
  Molecular Oncology, 2021
• β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression
  Immunity, 2021
• Chitinase-3 like-protein-1 function and its role in diseases
  Signal Transduction and Targeted Therapy, 2020
• Matrix Elasticity Directs Stem Cell Lineage Specification
  Cell, 2006